Johnson & Johnson ROI - Return on Investment 2010-2025 | JNJ

Johnson & Johnson return on investment for the quarter ending March 31, 2025 was 20.61.

  • Johnson & Johnson average return on investment for 2024 was 26.65, a 15.52% decline from 2023.
  • Johnson & Johnson average return on investment for 2023 was 23.07, a 26.27% increase from 2022.
  • Johnson & Johnson average return on investment for 2022 was 18.27, a 0.44% increase from 2021.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.

Johnson & Johnson ROI - Return on Investment 2010-2025 | JNJ

  • Johnson & Johnson average return on investment for 2024 was 26.65, a 15.52% decline from 2023.
  • Johnson & Johnson average return on investment for 2023 was 23.07, a 26.27% increase from 2022.
  • Johnson & Johnson average return on investment for 2022 was 18.27, a 0.44% increase from 2021.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$796.4B
AbbVie (ABBV)$306B
Novo Nordisk (NVO)$260.6B
Roche Holding AG (RHHBY)$248.1B
Novartis AG (NVS)$234.2B
Merck (MRK)$196.7B
Sanofi (SNY)$128.6B
Pfizer (PFE)$125.6B
Bayer (BAYRY)$23.7B
Innoviva (INVA)$1.1B